Saturday, October 24, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Researchbpc-157tendon injuryfda

Muscle & Fitness examines BPC-157 evidence behind viral injury claims

The consumer fitness title weighs the gap between social-media healing claims and the largely preclinical record for the peptide.

PR
By Priya Raman · Science Reporter
Oct 8 06:36 ETSource: Muscle & Fitness

The wire

  1. 01The article addresses BPC-157's reputation as a tendon and gut healing agent and asks whether the evidence supports the online claims.
  2. 02BPC-157 remains among the most-asked-about peptides for clinicians and compounders, and sits on FDA's problematic-ingredient list, so patient-facing coverage shapes demand.
  3. 03The published base is overwhelmingly rodent work with no adequate controlled human trials, a limitation readers should keep in view.

From the source

BPC-157 ‘Wolverine Peptide’: Does this Viral Injury Cure Actually Work?

Read at muscleandfitness.com
PeptiPrescribed peptides from $99/moSee all →